HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Riess Selected Research

Heparin (Liquaemin)

1/2018[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
1/2018[Bridging anticoagulation in patients receiving vitamin K antagonists : Current status].
5/2005[Therapeutic modulation of coagulation in sepsis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Riess Research Topics

Disease

16Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 09/2000
13Hemorrhage
01/2018 - 07/2001
12Neoplasms (Cancer)
01/2022 - 09/2000
10Hyperthermia
06/2006 - 01/2000
7Rectal Neoplasms (Rectal Cancer)
06/2006 - 01/2000
5Thrombosis (Thrombus)
10/2013 - 07/2001
5Carcinoma (Carcinomatosis)
01/2003 - 01/2000
4Adenocarcinoma
10/2020 - 09/2000
3Venous Thrombosis (Deep-Vein Thrombosis)
10/2023 - 07/2001
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2019 - 10/2009
3Lymphatic Metastasis
07/2013 - 10/2000
3Atrial Fibrillation
06/2013 - 10/2010
3Neoplasm Metastasis (Metastasis)
01/2006 - 04/2000
3Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 04/2000
2Pulmonary Embolism
10/2023 - 07/2001
2Thrombocytopenia (Thrombopenia)
10/2020 - 02/2006
2Thromboembolism
01/2018 - 01/2018
2Stroke (Strokes)
06/2013 - 01/2012
2Sepsis (Septicemia)
05/2005 - 06/2000
2Nausea
06/2004 - 01/2001
1Fatigue
10/2020
1Neutropenia
10/2020
1Hypertension (High Blood Pressure)
10/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Disease Progression
04/2015
1Pathologic Complete Response
04/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2014
1Pathologic Constriction (Stenosis)
09/2014
1Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2013
1Hemophilia A (Haemophilia)
10/2012
1Venous Thromboembolism
01/2012
1Renal Insufficiency (Renal Failure)
06/2011
1Polyps
10/2010
1Cholangiocarcinoma
08/2010
1Hemolysis
08/2010
1Epstein-Barr Virus Infections
02/2009
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2006
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2005
1Disseminated Intravascular Coagulation
05/2005

Drug/Important Bio-Agent (IBA)

13GemcitabineFDA Link
10/2020 - 09/2000
6Leucovorin (Folinic Acid)FDA Link
08/2013 - 09/2000
6Fluorouracil (Carac)FDA LinkGeneric
08/2010 - 09/2000
5AnticoagulantsIBA
08/2020 - 07/2001
4Rituximab (Mabthera)FDA Link
04/2015 - 02/2006
3Heparin (Liquaemin)FDA LinkGeneric
01/2018 - 05/2005
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2014 - 07/2004
3Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2013 - 06/2004
3certoparin (certoparin sodium)IBA
11/2011 - 06/2010
2Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2021 - 03/2011
2Biomarkers (Surrogate Marker)IBA
03/2019 - 08/2015
2Cisplatin (Platino)FDA LinkGeneric
08/2013 - 09/2002
2DabigatranFDA Link
06/2013 - 01/2012
2Blood Coagulation Factors (Coagulation Factor)IBA
10/2012 - 05/2005
2AntibodiesIBA
08/2010 - 02/2006
2AntithrombinsIBA
05/2005 - 06/2000
2CytokinesIBA
05/2005 - 05/2005
2CoumarinsIBA
07/2001 - 07/2001
1Sorafenib (BAY 43-9006)FDA Link
10/2020
1TransferasesIBA
10/2020
1Equilibrative Nucleoside Transporter 1IBA
08/2015
1ganitumabIBA
05/2015
1human MIR17HGIBA
11/2014
1Proteins (Proteins, Gene)FDA Link
05/2014
1Cysteine (L-Cysteine)FDA Link
05/2014
1ecarinIBA
06/2013
1prothrombin complex concentrates (PPSB)IBA
06/2013
1apixabanIBA
06/2013
1RivaroxabanIBA
06/2013
1Blood Group Antigens (Blood Groups)IBA
01/2013
1Factor IIaIBA
01/2012
1Monoclonal AntibodiesIBA
03/2011
1Panitumumab (Vectibix)FDA Link
03/2011
1Tyrosine Kinase InhibitorsIBA
03/2011
1Cetuximab (Erbitux)FDA Link
03/2011
1ErbB Receptors (EGF Receptor)IBA
03/2011
1Gefitinib (Iressa)FDA Link
03/2011
1Clopidogrel (Plavix)FDA Link
10/2010
1Intravenous Immunoglobulins (IVIG)FDA Link
02/2009
1Antiviral Agents (Antivirals)IBA
02/2009
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
05/2005
1drotrecogin alfa activated (Xigris)FDA Link
05/2005

Therapy/Procedure

20Therapeutics
10/2023 - 01/2000
18Drug Therapy (Chemotherapy)
01/2019 - 01/2000
7Chemoradiotherapy
06/2006 - 01/2000
5Radiotherapy
01/2014 - 09/2000
2Catheters
10/2001 - 09/2000
1Immunotherapy
01/2022
1Ambulatory Care (Outpatient Care)
08/2020
1Organ Transplantation
11/2014
1Image-Guided Radiotherapy
01/2014
1Combined Modality Therapy
01/2014
1Induction Chemotherapy
01/2014
1Brachytherapy
07/2013
1Surgical Instruments (Clip)
10/2010
1Length of Stay
01/2008
1Combination Drug Therapy (Combination Chemotherapy)
01/2008
1Platelet Transfusion (Blood Platelet Transfusions)
11/2006
1Neoadjuvant Therapy
06/2006
1Induced Hyperthermia (Thermotherapy)
01/2006
1Lasers (Laser)
01/2006